your market intelligence analyst
Search Results
304 results
Your search is now limited to «Partnerships and Collaborations» expert search.
Business Wire 08/23/2019 16:01
The collaboration reflects Gilead's intent to grow our innovation network through diverse and creative partnerships.
More from Business Wire:
ENDPOINTS 08/23/2019 07:28
Eli Lilly is expanding its partnership with China’s Innovent in a deal involving a diabetes drug sitting in its Phase I reserves.
More from ENDPOINTS:
This collaboration reflects a shared commitment to the goal of improving the lives of cancer patients in meaningful ways.
More from Healthcare Sales & Marketing Network:
MedCity News 08/06/2019 14:14
The partnership between the two companies has paid off in other ways as well.
More from MedCity News:
OutSourcing-Pharma 08/06/2019 10:37
According to the spokesperson, this trend is exemplified by partnerships between Japan-based pharma companies and biotechs, including AstraZeneca and Daiichi Sankyo, Genentech and Sosei Heptares, as well the partnership between Takeda and Sosei.
More from OutSourcing-Pharma:
Beauty Packaging 08/05/2019 09:55
The partnership will combine the proprietary GPCR-focused structure-based drug design capabilities at Sosei Heptares with Takeda’s extensive discovery, development and therapeutic area expertise directed towards multiple GPCR targets nominated by Takeda.
More from Beauty Packaging:
GlobeNewswire 08/05/2019 09:00
Sanofi has commenced dosing of DNL758 in a Phase 1 healthy volunteer study.
More from GlobeNewswire:
pharmaphorum 08/05/2019 06:24
The deal comes just three weeks after a $1 billion tie-up with Roche’s Genentech unit across a range of diseases, once again with a $26m upfront package, with the new partners joining a lengthy list that includes companies like Pfizer, AstraZeneca, Allergan, Novartis, and Daiichi-Sankyo.
More from pharmaphorum:
PharmaTimes 08/05/2019 06:11
Sosei Heptares and Takeda have entered into new strategic multi-target research, development and commercialisation partnership to combine Sosei’s structure-based drug design capabilities with Takeda’s discovery, development and therapeutic area expertise.
More from PharmaTimes:
PR Newswire 08/05/2019 02:30
Our additional partners and collaborators include Takeda, Genentech, Novartis, Pfizer, Daiichi-Sankyo, PeptiDream, Kymab and MorphoSys.
More from PR Newswire:
FierceMedicalDevices 08/04/2019 05:02
GlycoMimetics shares nearly cut in half as Pfizer-partnered phase 3 drug flops.
More from FierceMedicalDevices: 07/29/2019 22:52
In 2011, Bayer entered into an agreement with Onyx, now an Amgen subsidiary, under which Onyx receives a royalty on all global net sales of regorafenib in oncology.
More from
Pharmafile 07/29/2019 06:02
Sanofi ends partnership with Lexicon after release of Phase 3 data.
More from Pharmafile:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications